## GFS: GLOBALFOUNDRIES Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -5.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($33.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. GlobalFoundries Accelerates and Strengthens Europe’s Semiconductor Ecosystem through Strategic Partnership with Cloudberry**
- Source: WebWire | 20251223T230916 | Bullish | Relevance: 100%
- GlobalFoundries (GF) has partnered with Finnish venture capital firm Cloudberry to strengthen Europe's semiconductor and photonics startup ecosystem. GF will participate as a limited partner in Cloudberry’s new fund and provide technology expertise to help emerging companies scale. This collaboration aims to deepen Europe’s innovation ecosystem by connecting GF's technology roadmap with promising new applications and bridging the gap from research to production for startups.

**2. Onsemi partners with GLOBALFOUNDRIES to develop 650V GaN power products - CHOSUNBIZ**
- Source: Chosunbiz | 20251222T030912 | Bullish | Relevance: 100%
- Onsemi has partnered with GLOBALFOUNDRIES to develop 650V GaN power products. This collaboration aims to leverage the expertise of both companies in advanced semiconductor manufacturing. The partnership signifies a strategic move to enhance technology in the power semiconductor market.

**3. GlobalFoundries Stock (GFS) Today: Latest News, Analyst Forecasts, and the 2026 Setup (Dec. 21, 2025)**
- Source: ts2.tech | 20251221T130919 | Somewhat-Bullish | Relevance: 100%
- GlobalFoundries (GFS) is navigating the end of 2025 with strategic moves in specialized semiconductor manufacturing, focusing on areas like GaN power devices and silicon photonics, which are crucial for AI infrastructure. Recent developments include a new CFO appointment, key partnerships, and significant European funding, positioning the company for growth outside the bleeding-edge AI chip race. While analyst forecasts are mixed, the company's focus on "Physical AI" and strategic differentiation suggests a long-term growth trajectory for investors looking beyond traditional AI compute exposure.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | B of A Securiti | $37 | $33 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | B of A Securiti | main | Underperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 95.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 0 |

**Top Holders:**
- Mubadala Investment : 81.5% (0.0%)
- FMR, LLC: 9.4% (+0.8%)
- Blackrock Inc.: 0.7% (+0.6%)
- Citadel Advisors Llc: 0.5% (+31.2%)
- Invesco Ltd.: 0.5% (+7.9%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. High short interest (17.6%, 4.8 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.64 indicates undervaluation relative to growth. Balance sheet: strong liquidity (3.0x), low leverage (D/E 0.42). Analyst sentiment positive (1 raises, avg +12%). Institutional flow bullish (9 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.9B |
| Beta | 1.48 |
| 52W Range | $29.77 - $47.69 |
| Short Interest | 17.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.64 |
| Forward P/E | 18.9 |
| Current P/E | 21.8 |
| YoY Growth | 15.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -3.4% to -5.7% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >3.0% for momentum thesis). Underperforming sector by 5.9pp, stock-specific weakness. Below SMA200 (0.99x), long-term trend not supportive. RSI neutral at 45. OFD pattern: -MUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.70% (CS: 4) | Weak |
| RSI_14 | 44.9 | Neutral |
| MACD Histogram | -0.39 | Bearish |
| vs SMA20 | 0.957x | Below |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 0.994x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $35.79
- **Stop Loss:** $33.27 (7.0% risk)
- **Target:** $38.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 476
- **Position Value:** $17,036.04
- **Portfolio %:** 17.04%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-10 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.41 | +5.4% |
| 2025Q2 | $0.36 | $0.42 | +17.0% |
| 2025Q1 | $0.29 | $0.34 | +17.8% |
| 2024Q4 | $0.45 | $0.46 | +1.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*